Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 1999, p. 464-466, Vol. 37, No. 2
Children's Hospital1
and
Institute of Bacteriology,2 General
Hospital Salzburg, Salzburg, Austria
Received 11 June 1998/Returned for modification 22 July
1998/Accepted 2 November 1998
Broad-range PCR has proven to be useful for the detection of
bacteria. A set of broad-range PCR primers directed against conserved regions in the 16S rRNA gene was designed to specifically amplify either gram-positive or gram-negative bacteria. The gram type-specific broad-range PCR correctly classified all 62 pathogenic species tested.
Antibiotic treatment of bacterial
infections depends on the species of bacteria, with the differentiation
between gram positive or gram negative being one of the most important
factors. A 100% sensitive and specific method for the identification
of the presence of bacteria in usually sterile body fluids would allow
for earlier initiation of targeted antibiotic treatment. Recent studies
suggest that rapid detection systems can decrease patient mortality
rates and costs associated with hospitalization (1).
Currently, therapy is usually empiric, involving use of a
broad-spectrum antibiotic until culture results are available.
Standard diagnosis of systemic bacterial infection depends on growth in
culture, which requires at least 12 to 72 h for detection. The
most rapid tests are latex agglutination tests and Gram stains, which
are less sensitive than culture and molecular methods (6). Molecular biological methods for detection of nucleic acids have been
shown to have greater sensitivity than immunological and staining
methods. The use of PCR primers that target DNA regions that are
conserved in bacteria for the purposes of DNA sequencing and
detection of bacteremia has been described (2). A recent study employed a universal bacterial broad-range PCR in combination with Southern blot hybridization with probes for differentiation of gram-positive and gram-negative species (3). Here,
we report a gram type-specific PCR for the differentiation of a wide
range of pathogenic gram-positive and gram-negative bacteria.
This technique will allow detection and differentiation
between gram-positive bacteria and gram-negative bacteria and
is more rapid and less time-consuming than Southern blot analysis
of the PCR products for gram differentiation.
Pure bacterial isolates were derived from cultures of clinical
specimens which were analyzed by conventional procedures at the
Institute of Bacteriology, Salzburg, Austria. These specimens included
blood, sputum, cerebrospinal fluid, and different kinds of swabs and
feces. After a 24-h incubation on solid medium, single colonies were
resuspended in 200 µl of phosphate-buffered saline and pelleted by
centrifugation. The pellet was then resuspended in 50 µl of a
solution containing 20 mM
(NH4)2SO4, 75 mM Tris-HCl (pH 9.0),
0.5% Tween 20, 0.5% Triton X-100, and 5 mg of proteinase K/ml and
incubated at 60°C for 1 h, followed by an incubation at 95°C
for 10 min.
Universal broad-range PCR was carried out by using primers DG74 and
65ab (5'-AACTGGAGGAAGGTGGGGAY-3') as described previously (3). Position 20 at the 3'-end in the universal primer 65ab is degenerated since there is no single signature which is present in
all bacteria. DNA (2 µl) was amplified in a final volume of 30 µl
containing 20 mM (NH4)2SO4, 75 mM Tris-HCl (pH 9.0), 0.1% Tween, 2.5 mM MgCl2, 200 µM
(each) deoxynucleoside triphosphates, 10 pmol of each primer, and 1 U
of Red Hot DNA polymerase (Advanced Biotechnology, Epsom, United
Kingdom). To destroy endogenous bacterial DNA present in the reagents,
the reaction mixture was exposed to UV light (320 nm) for 5 min in
the presence of 38 nM 5-methoxypsoralen before the addition of the
DNA (7). The mixture was incubated at 95°C for 5 min,
followed by 45 cycles of 95°C for 30 s, 69°C for 30 s,
and 72°C for 10 s.
Single oligonucleotide primers were constructed with sequences
unique to gram-positive bacteria and gram-negative bacteria, respectively. The gram-positive- and gram-negative-specific primers differ at the 3'-end, where a C residue is present in
all gram-positive species analyzed and a G residue is present in
all gram-negative species (Fig. 1). For
the gram-positive-specific PCR, the primer 143 (5'-GAYGACGTCAARTCMTCATGC-3') and the universal primer
DG74 were used with the same reaction conditions as described for
amplification using the universal primers except that the annealing
temperature was 65°C and 50 cycles were performed. For the
gram-negative-specific PCR, the primer 68d
(5'-AYGACGTCAAGTCMTCATGG-3') and the universal primer DG74
were used under the same reaction conditions as described for
amplification using the universal primers except that the concentration
of MgSO4 was 1.75 mM and 50 cycles were performed. Amplification with 45 and 50 cycles never gave a PCR product in the
negative control reaction. Blood of control patients was spiked with a
defined number of CFU of Escherichia coli and
Staphylococcus aureus for the determination of the
sensitivity of gram type-specific PCRs. For isolation of human genomic
DNA from whole blood, erythrocytes were lysed in 150 mM
NH4Cl-10 mM NaHCO3-1 mM EDTA. After
centrifugation, the DNAs of remaining leukocytes and bacteria were
isolated with the DNAzol method according to the manufacturer's
protocol (Molecular Research Center Inc., Cincinnati, Ohio). The
sensitivity of the gram-negative-specific PCR was 101 CFU
of E. coli per PCR and that of the gram-positive-specific PCR was 103 CFU of S. aureus (data not shown).
Processing of blood and the amplification conditions for the
gram-positive-specific PCR in low-titer clinical samples might have to
be optimized for its application in routine diagnosis. No specific
amplification of human or fungal DNA was observed when it was added to
the PCR mixtures. The addition of 100 ng of human DNA did not influence PCR performance (data not shown), an important consideration when DNA
is isolated directly from clinical samples. With all 116 different bacterial species tested in this study, only one signal was detected either with gram-positive or gram-negative-specific primers, but all
samples showed a signal after universal broad-range PCR (Fig. 2, Table
1). Of the 116 clinical isolates, 46 were
classified as gram positive by conventional methods and also as gram
positive by gram type-specific PCR (Table 1). The balance of the
samples were classified as gram negative by routine analysis and also specifically amplified by PCR (Table 1). Figure 2 shows a
representative example for the results of the universal and gram
type-specific PCRs of a sample of clinical isolates. Faint bands were
sometimes seen in gram-negative-specific PCR (Fig. 2C, lanes 5 and 9)
with DNA from gram-positive bacteria. If in further studies these bands occur when clinical samples are analyzed it should be sufficient to
consider the strongest band.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Gram Type-Specific Broad-Range PCR Amplification
for Rapid Detection of 62 Pathogenic Bacteria
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (32K):
[in a new window]
FIG. 1.
Alignment of gram-positive and gram-negative primer
sequences with nucleotide sequences of the 16S rRNA genes of different
bacterial species. Residues identical to those of primers are indicated
by dashes. Positions which do not match primer sequence are shown in
italics. Gram type-specific residues are shown in boldface type.
Nucleotide positions corresponding to the E. coli reference
sequence are depicted at the top of the figure.

View larger version (70K):
[in a new window]
FIG. 2.
Detection of bacterial DNA in clinical isolates by
broad-range PCR. (A) Universal PCR with primers DG74 and 65ab. (B)
Gram-positive-specific PCR with primers DG74 and 143. (C)
Gram-negative-specific PCR with primers DG74 and 68d. PCR products were
analyzed by 2% agarose gel electrophoresis and ethidium bromide
staining. Lanes M, molecular size markers; lanes 1, Bacillus
subtilis; lanes 2, Citrobacter species; lanes 3, Corynebacterium species; lanes 4, Enterobacter
cloacae; lanes 5, Enterococcus species; lanes 6:
E. coli; lanes 7, K. pneumoniae; lanes 8, Serratia liquefaciens; lanes 9, S. aureus; lanes
10, Streptococcus pneumoniae; lanes 11, negative control.
TABLE 1.
Summary of results of universal PCR,
gram-negative-specific PCR, and gram-positive-specific PCR of
pathogenic bacteria
It seems that for the gram-specific broad-range PCR, only one difference in the primer sequence at the last base at the 3'-end is sufficient for gram specificity (Fig. 1). Although the sequence of the target 16S rRNA gene from some of the bacterial species does not match completely the sequence of the gram type-specific primers that we have designed, the specificity of the gram type-specific PCR was not influenced. Surprisingly, three mismatches in the primer sequence to Prevotella melaninogenica do not alter the specificity of the amplification reaction. However, to restore sensitivity, the annealing temperature of the gram-negative-specific PCR for P. melaninogenica had to be lowered by 4°C (data not shown). Therefore, only in the few cases where there is a positive signal in universal PCR but no product with either gram-positive- or gram-negative-specific PCR would a fourth PCR for gram-negative bacteria at 65°C have to be performed.
Many of the bacterial species investigated here, such as Klebsiella pneumoniae and S. aureus, which cause pneumonia and septicemia, respectively, are common pathogens. Other studies have shown that universal broad-range PCR is a rapid diagnostic tool for the detection of bacteria in clinical specimens; however, gram classification was not performed (2, 4, 5, 8). The gram type-specific broad-range PCR could form the basis for the development of a rapid and sensitive procedure for the detection and preliminary classification of bacteria in clinical specimens. This would allow the early choice of specific antibiotic treatment targeted to either gram-positive or gram-negative bacterial species. Conventional microbiological methods would still be required for confirmation of bacterial infection, identification of the species, and determination of the antibiotic susceptibility of any bacteria isolated.
| |
ACKNOWLEDGMENTS |
|---|
These studies were supported by the Children's Cancer Foundation Salzburg.
We thank Tiina P. Iismaa for critical review of the manuscript and Manfred Müller for the support in this work.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Children's Hospital, General Hospital Salzburg, Müllner Hauptstr. 48, A-5020 Salzburg, Austria. Phone: 43 662 4482 2650. Fax: 43 662 4482 2604. E-mail: b.kofler{at}lkasbg.gv.at.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Doern, G. V.,
M. Vautour,
M. Gaudet, and B. Levy.
1994.
Clinical impact of rapid in vitro susceptibility testing and bacterial identification.
J. Clin. Microbiol.
32:1757-1762 |
| 2. | Goldenberger, D., A. Künzli, P. Vogt, R. Zbinden, and M. Altwegg. 1997. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J. Clin. Microbiol. 35:2733-2739[Abstract]. |
| 3. |
Greisen, K.,
M. Loeffelholz,
A. Purohit, and D. Leong.
1994.
PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid.
J. Clin. Microbiol.
32:335-351 |
| 4. | Kane, T. D., J. Alexander, and J. Johannigman. 1998. The detection of microbial DNA in the blood: a sensitive method for diagnosing bacteremia and/or bacterial translocation in surgical patients. Ann. Surg. 227:1-9[Medline]. |
| 5. | Laforgia, N., B. Coppola, R. Carbone, A. Grassi, A. Mautone, and A. Iolascon. 1997. Rapid detection of neonatal sepsis using polymerase chain reaction. Acta Paediatr. 86:1097-1099[Medline]. |
| 6. |
La Scolea, L. J., and D. Dryja.
1984.
Quantification of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance.
J. Clin. Microbiol.
19:187-190 |
| 7. |
Meier, A.,
D. H. Persing,
M. Finken, and E. C. Böttger.
1992.
Elimination of contaminating DNA within polymerase chain reaction reagents: implications for a general approach to detection of uncultured pathogens.
J. Clin. Microbiol.
31:646-652 |
| 8. | Wilbrin, B., I. M. van der Heijden, L. M. Schouls, J. D. van Emden, J. M. Hazes, F. C. Breedveld, and P. P. Tak. 1998. Detection of bacterial DNA in joint samples from patients with undifferentiated arthritis and reactive arthritis, using polymerase chain reaction with universal 16S ribosomal RNA primers. Arthritis Rheum. 41:535-543[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»